Envoy Medical, Inc. (COCH) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$0.65

From 52W high−27.44%

Volume104356.00

Market cap$50.62M

P/E (TTM)—

P/S (TTM)244.5x

Div yield—

Key dataOct 19, 2026

Open

$0.65

From 52W high

−27.44%

Volume

104356.00

Market cap

$50.62M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.5x

P/E (TTM)

—

RSI (14)

47.2

MomentumView details →

1D Return

−2.10%

YTD Return

+1.04%

SummaryUpdated Jun 1, 2026

Envoy Medical, Inc. (NASDAQ:COCH) is a hearing health company founded in 1995 and headquartered in White Bear Lake, Minnesota. Originally established as St. Croix Medical, Inc., the company changed its name to Envoy Medical Corporation in December 2004 before becoming Envoy Medical, Inc. The company went public in April 2021 and develops medical technologies designed to address various forms of hearing loss across the hearing loss spectrum.

Ask drillr about Envoy Medical, Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−1.5x

EV/Sales

153.4x

P/S (TTM)

244.5x

P/B (TTM)

15.3x

ProfitabilityView details →

Gross Margin

−385.51%

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−708.48%

ROA (TTM)

−97.71%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

−6.76%

EPS YoY

+49.80%

FCF YoY

−40.36%

Revenue CAGR 3Y

+0.56%

EPS CAGR 3Y

+17.45%

EBITDA YoY

−13.22%

MomentumView details →

1D Return

−2.10%

YTD Return

+1.04%

1Y Return

−20.76%

RSI (14)

47.2

vs 50D SMA

−5.35%

vs 200D SMA

−3.12%

Capital & dividendView details →

Debt/Equity

0.25x

Current Ratio

1.73x

Quick Ratio

1.61x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.07

EPS Surprise

12.50%

Beats (12Q)

3/12

Next Q EPS Est

−$0.07

Avg Surprise (4Q)

3.81%

Rev Surprise

2.00%

Financials snapshotView financials →

Revenue (TTM)

207000.00

Net Income (TTM)

−23.40M

Op. CF (TTM)

−21.53M

Next earningsNov 9, 2026 →

Latest newsMore news →

Envoy Medical, Inc. appointed Robert Potashnick as Chief Accounting Officer and Vice President of Finance, effective August 24, 2026.54d ago

Envoy Medical reported financial results for the second quarter ended June 30, 2026, on August 10, 2026.70d ago

Similar companies

Spectral AI, Inc.MDAI Inspira Technologies Oxy B.H.N. Ltd.IINN Sensus Healthcare, Inc.SRTS TELA Bio, Inc.TELA Hyperion DeFi, Inc.HYPD SANUWAVE Health, Inc.SNWV Find similar companies →

Latest newsMore news →

Envoy Medical, Inc. appointed Robert Potashnick as Chief Accounting Officer and Vice President of Finance, effective August 24, 2026.54d ago Envoy Medical reported financial results for the second quarter ended June 30, 2026, on August 10, 2026.70d ago Envoy Medical announced that all 56 patients in its pivotal clinical trial for the Acclaim cochlear implant have passed the three-month visit milestone.90d ago